Abstract
Clomipramine (25 mg) taken as needed increases ejaculatory latency in men with rapid ejaculation (RE), although only about half the men treated respond to this regimen. It would therefore be clinically advantageous to know the patient's potential responsiveness to an ‘as needed’ regimen prior to treatment. The present study attempted to identify a priori factors that might enable prediction of patients' response or nonresponse to ‘as needed’ clomipramine. Variables relevant to rapid ejaculation were examined in 23 men with RE, 12 of whom had responded to clomipramine. Logistic regression indicated that three factors assessed prior to treatment—initial ejaculation latency, overall sexual satisfaction, and ejaculation frequency each week—significantly improved the prediction of responsiveness to this treatment regimen. Specifically, RE men with initial ejaculatory latencies over 60 s, self-reported sexual satisfaction of 5 or higher (on a seven-point scale), and ejaculation frequency of twice or more weekly were more likely to benefit from 25 mg ‘as needed’ clomipramine. As such, men meeting these criteria might be considered for this treatment regimen. Those not matching these characteristics might better be considered for 20 or 30 mg clomipramine given on a daily basis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Althof SE . Pharmacologic treatment of rapid ejaculation. Psychiatr Clin North Am 1995; 18: 85–94.
McMahon CG . Treatment of premature ejaculation with sertraline hydrochloride. Int J Impot Res 1998; 10: 181–184.
Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B . Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998; 18: 274–281.
Haensel SM, Rowland DL, Kallan K, Slob AK . Clomipramine and sexual function in men with premature ejaculation and controls. J Urol 1996; 56: 1310–1315.
Strassberg DS et al. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marit Ther 1998; 25: 89–101.
Rowland DL, Brazao de Gouveia C, Slob AK . Effective daily treatment with clomipramine in men with premature ejaculation when 25 mg (as required) is not effective. Br J Urol 2001; 87: 357–360.
Rowland DL, Slob AK . Assessment of sexual health: premature ejaculation. (online); CD-ROM. Abstracts from Ovid Technologies, HaPI Item 209897 2000.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn., text revision. American Psychiatric Association: Washington, DC, 2000, 943pp.
Rowland DL, Cooper SE, Schneider M . Defining premature ejaculation for experimental and clinical investigations. Arch Sex Behav 2001; 30: 235–254.
Rowland DL . Treatment of premature ejaculation: selecting outcomes to determine efficacy. Int Soc Sex Impot Res Newsbull 2003; 10: 26–27.
Kaplan HS . Premature Ejaculation: Overcoming Premature Ejaculation. Bruner/Mazel: New York, 1989.
Spiess WS, Geer J, O'Donohue WT . Premature ejaculation: investigation of factors in ejaculatory latency. J Abnorm Psychol 1984; 93: 242–245.
Grenier G, Byers S . Operationalizing premature or rapid ejaculation. J Sex Res 2001; 38: 369–378.
Masters WH, Johnson VE . Human Sexual Inadequacy. Little, Brown: Boston, 1970, pp 92–115.
Balon R, Yeragani VK, Pohl R, Ramesh C . Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993; 54: 209–212.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rowland, D., Tai, W., Brummett, K. et al. Predicting responsiveness to the treatment of rapid ejaculation with 25 mg clomipramine as needed. Int J Impot Res 16, 354–357 (2004). https://doi.org/10.1038/sj.ijir.3901161
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901161
Keywords
This article is cited by
-
Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation
International Journal of Impotence Research (2008)
-
Late‐stage clinical development in lower urogenital targets: sexual dysfunction
British Journal of Pharmacology (2006)
-
Men?s Aging and Sexual Disorders: An Update on Diagnosis and Treatment
Reviews in Endocrine and Metabolic Disorders (2005)